Do you want to read an article? Please log in or register.
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database
Multiple Sclerosis
Related content
Further Publications NeurologyFurther Publications Psychiatry
Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System
Psychother Psychosom.
Gastaldon C, Raschi E, Kane JM, Barbui C, Schoretsanitis G
doi: 10.1159/000510703.
Migraine and Headache
Neurological adverse events associated with immune checkpoint inhibitors: Review of the literature
Eur J Cancer.
Cuzzubbo S, Javeri F, Tissier M, Roumi A, Barlog C, Doridam J, Lebbe C, Belin C, Ursu R, Carpentier AF
doi: 10.1016/j.ejca.2016.12.001.
Migraine and Headache
Restless legs-like syndrome as an emergent adverse event of CGRP monoclonal antibodies: A report of two cases
Cephalalgia
González-Quintanilla V, Pérez-Pereda S, González-Suárez A, Madera J, Toriello M, Pascual J
doi: 10.1177/03331024211017879
Stroke
Association of Ticagrelor vs Clopidogrel With Net Adverse Clinical Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
JAMA
You SC, Rho Y, Bikdeli B, Kim J, Siapos A, Weaver J, Londhe A, Cho J, Park J, Schuemie M, Suchard MA, Madigan D, Hripcsak G, Gupta A, Reich CG, Ryan PB, Park RW, Krumholz HM
doi: 10.1001/jama.2020.16167
Further Publications Psychiatry
The association between placebo arm inclusion and adverse event rates in antidepressant randomized controlled trials: An examination of the Nocebo Effect
J Affect Disord
Cheung CP, Thiyagarajah MT, Abraha HY, Liu CS, Lanctôt KL, Kiss AJ, Saleem M, Juda A, Levitt AJ, Schaffer A, Cheung AH, Sinyor M
doi: 10.1016/j.jad.2020.11.004
RECOMMENDED
Migraine and Headache
Safety profile of erenumab, galcanezumab and fremanezumab in pregnancy and lactation: Analysis of the WHO pharmacovigilance database
★ 2
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Cephalalgia
Noseda R, Bedussi F, Gobbi C, Zecca C, Ceschi A
doi: 10.1177/0333102420983292
Beneficial effect of tocilizumab in myasthenia gravis refractory to rituximab
Neuromuscul Disord.
Jonsson DI, Pirskanen R, Piehl F
doi: 10.1016/j.nmd.2017.03.007.
Multiple Sclerosis
Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis
Cochrane Database Syst Rev.
Filippini G, Del Giovane C, Clerico M, Beiki O, Mattoscio M, Piazza F, Fredrikson S, Tramacere I, Scalfari A, Salanti G
doi: 10.1002/
Further Publications Psychiatry
The impact of prenatal stressful life events on adverse birth outcomes: A systematic review and meta-analysis
J Affect Disord
Ding X, Liang M, Wu Y, Zhao T, Qu G, Zhang J, Zhang H, Han T, Ma S, Sun Y
doi: 10.1016/j.jad.2021.03.083